MONOCLONAL ANTIBODIES TREATMENT

Brand Owner (click to sort) Address Description
NOSONATE GLAXOSMITHKLINE BIOLOGICALS S.A. RUE DE L'INSTITUT 89 RIXENSART B-1330 Belgium monoclonal antibodies for the treatment and/or prevention of bacterial infections;
NOSOSTAPH BIOSYNEXUS INCORPORATED 9298 GAITHER ROAD GAITHERSBURG MD 20877 monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus; monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus;
NOSOTEK BIOSYNEXUS INCORPORATED 9298 GAITHER ROAD GAITHERSBURG MD 20877 monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus; monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus;
NOSOTEQ GLAXOSMITHKLINE BIOLOGICALS MANUFACTURING S.A. RUE DE L'INSTITUT 89 RIXENSART B-1330 Belgium monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus; monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus;
PREMABTEC GLAXOSMITHKLINE BIOLOGICALS S.A. RUE DE L'INSTITUT 89 RIXENSART B-1330 Belgium monoclonal antibodies for the treatment and/or prevention of bacterial infections;
PREMASTAPH GLAXOSMITHKLINE BIOLOGICALS S.A. RUE DE L'INSTITUT 89 RIXENSART B-1330 Belgium monoclonal antibodies for the treatment and/or prevention of bacterial infections;
PREMAVANCE GLAXOSMITHKLINE BIOLOGICALS S.A. RUE DE L'INSTITUT 89 RIXENSART B-1330 Belgium monoclonal antibodies for the treatment and/or prevention of bacterial infections;
STAPHBREAK GLAXOSMITHKLINE BIOLOGICALS MANUFACTURING S.A. RUE DE L'INSTITUT 89 RIXENSART B-1330 Belgium monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus; monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus;STAPHYLOCOCCAL BREAK;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides monoclonal antibodies and humanized antibodies which react specifically with a human interleukin-5 receptor ? chain. The invention also provides hybridomas and transformants which produce the antibodies, the monoclonal antibodies and humanized antibodies, a method for detecting an interleukin-5 receptor ? chain immunologically by means of these antibodies, as well as a method for diagnosing and treating diseases such as chronic bronchial asthma by means of the monoclonal antibodies and humanized antibodies. The present invention is useful for diagnosis or treatment of diseases such as chronic bronchial asthma.